http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012106432-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57442 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3069 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2010-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2012106432-A |
| titleOfInvention | MARKERS FOR CANCER ENDOMETRY |
| abstract | 1. An in vitro diagnostic method for the diagnosis of endometrial cancer, which includes (1) determining the level of 1 to 17 biomarkers (s) selected from P4HB, GMIP, IKBKE, FASTKD1, DDR1, SIRT6, PHKG2, ACAA1, AP1M2, EPS8L2, P2RX4 , PPFIBP2, PPP1R16A, CGN, RASSF7, RNF183, and TJP3 in a sample from a patient, where an increased level of the indicated from 1 to 17 biomarkers compared to the control value indicates the existence of endometrial cancer and / or (2) determination of the level from 1 to 3 biomarkers selected from EFEMP2, SOCS2 and DCN, where a reduced level of EFEMP2, SOCS2, and / or DCN compared to the control value indicates the existence of endometrial cancer. 2. An in vitro diagnostic method in accordance with claim 1, which includes determining the level of P4HB. 3. The in vitro diagnostic method according to claim 1, which includes determining the level of EFEMP2.4. The in vitro method according to claim 1, which includes determining the level of IKBKE. 5. The in vitro diagnostic method according to claim 1, which includes determining the level of GMIP. 6. The in vitro diagnostic method according to claim 2, which further includes determining the level of one or more GMIP, IKBKE, or EFEMP2.7. An in vitro diagnostic method according to claim 3, which further includes determining the level of one or more P4HB, IKBKE, or GMIP. An in vitro diagnostic method according to claim 4, which further includes determining the level of one or more GMIP, EFEMP2, or P4HB. 9. The in vitro diagnostic method in accordance with claim 2, which further includes determining the level of FASTKD1.10. The in vitro diagnostic method in accordance with claim 2, which further includes determining the level of DDR1.11. The in vitro diagnostic method in accordance with claim 2, which further includes determining |
| priorityDate | 2009-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 694.